uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Improving public health by improving clinical trial guidelines and their application
Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England..
Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands..
Servier, Paris, France..
IDDI, Louvain La Neuve, Belgium.;CluePoints, Louvain La Neuve, Belgium.;Univ Hasselt, Hasselt, Belgium..
Show others and affiliations
2017 (English)In: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. 38, no 21, 1632-1637B p.Article in journal (Refereed) Published
Abstract [en]

Evidence generated from randomized controlled trials forms the foundation of cardiovascular therapeutics and has led to the adoption of numerous drugs and devices that prolong survival and reduce morbidity, as well as the avoidance of interventions that have been shown to be ineffective or even unsafe. Many aspects of cardiovascular research have evolved considerably since the first randomized trials in cardiology were conducted. In order to be large enough to provide reliable evidence about effects on major outcomes, cardiovascular trials may now involve thousands of patients recruited from hundreds of clinical sites in many different countries. Costly infrastructure has developed to meet the increasingly complex organizational and operational requirements of these clinical trials. Concerns have been raised that this approach is unsustainable, inhibiting the reliable evaluation of new and existing treatments, to the detriment of patient care. These issues were considered by patients, regulators, funders, and trialists at a meeting of the European Society of Cardiology Cardiovascular Roundtable in October 2015. This paper summarizes the key insights and discussions from the workshop, highlights subsequent progress, and identifies next steps to produce meaningful change in the conduct of cardiovascular clinical research.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS , 2017. Vol. 38, no 21, 1632-1637B p.
Keyword [en]
Clinical trials, Pragmatic clinical trials, Randomized controlled trials, Cardiovascular diseases
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:uu:diva-327135DOI: 10.1093/eurheartj/ehx086ISI: 000402720300006PubMedID: 28329235OAI: oai:DiVA.org:uu-327135DiVA: diva2:1137121
Available from: 2017-08-30 Created: 2017-08-30 Last updated: 2017-08-30Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

James, Stefan K

Search in DiVA

By author/editor
James, Stefan K
By organisation
Cardiology
In the same journal
European Heart Journal
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 94 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf